1-50419077-A-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_032110.3(DMRTA2):c.1217T>A(p.Leu406Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00343 in 1,260,936 control chromosomes in the GnomAD database, including 21 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_032110.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DMRTA2 | NM_032110.3 | c.1217T>A | p.Leu406Gln | missense_variant | 3/3 | ENST00000404795.4 | NP_115486.1 | |
DMRTA2 | XM_011541937.3 | c.1217T>A | p.Leu406Gln | missense_variant | 2/2 | XP_011540239.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DMRTA2 | ENST00000404795.4 | c.1217T>A | p.Leu406Gln | missense_variant | 3/3 | 5 | NM_032110.3 | ENSP00000383909.3 | ||
DMRTA2 | ENST00000418121.5 | c.1217T>A | p.Leu406Gln | missense_variant | 2/2 | 1 | ENSP00000399370.1 |
Frequencies
GnomAD3 genomes AF: 0.00264 AC: 394AN: 149502Hom.: 2 Cov.: 34
GnomAD3 exomes AF: 0.00168 AC: 14AN: 8328Hom.: 1 AF XY: 0.00178 AC XY: 9AN XY: 5060
GnomAD4 exome AF: 0.00354 AC: 3939AN: 1111324Hom.: 19 Cov.: 29 AF XY: 0.00356 AC XY: 1913AN XY: 536674
GnomAD4 genome AF: 0.00262 AC: 392AN: 149612Hom.: 2 Cov.: 34 AF XY: 0.00259 AC XY: 189AN XY: 73000
ClinVar
Submissions by phenotype
not specified Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Jul 09, 2019 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 14, 2023 | The c.1217T>A (p.L406Q) alteration is located in exon 3 (coding exon 2) of the DMRTA2 gene. This alteration results from a T to A substitution at nucleotide position 1217, causing the leucine (L) at amino acid position 406 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at